TickerFactsScreenerDevelopers

Krystal Biotech, Inc. (KRYS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $1.92M2017: $49.59M2018: $103.67M2019: $187.51M2020: $268.27M2021: $341.25M2022: $161.90M2023: $358.33M2024: $344.87M2025: $496.30M$496.30M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$496.30M+43.9%
2024$344.87M-3.8%
2023$358.33M+121.3%
2022$161.90M-52.6%
2021$341.25M+27.2%
2020$268.27M+43.1%
2019$187.51M+80.9%
2018$103.67M+109.1%
2017$49.59M+2478.8%
2016$1.92M—